SEC 13F Intelligence

Bios Capital Management, LP / CGTX

Bios Capital Management, LP’s Cognition Therapeutics Inc Position

Does Bios Capital Management, LP own Cognition Therapeutics Inc (CGTX)? Yes — 6.00M shares worth $5M (+8.63% of its 13F portfolio) as of Q1 2026.

Position Value
$5M
Q1 2026
Shares
6.00M
% of Portfolio
+8.63%
Quarters Held
6
currently held

Position History CGTX

Reported value by quarter
Q4 ’24: $4MQ4 ’24Q1 ’25: $3MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $8MQ3 ’25Q4 ’25: $8MQ4 ’25Q1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.00M$5M+8.63%
Q4 20256.00M$8M+9.80%
Q3 20256.00M$8M+9.11%
Q2 20256.00M$2M+2.56%
Q1 20256.00M$3M+3.19%
Q4 20246.00M$4M+4.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bios Capital Management, LP’s full portfolio or all institutional holders of CGTX.